Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country

Clinics and Practice

Mirela Šambić-Penc¹  Suzana Erić¹  Ilijan Tomaš¹  Renata Dobrila-Dintinjana²  Marin Golčić²  Goran Golčić²  Aleksandra Stevanović³  Lidija Gović-Golčić⁴  Martina Baretić Marinac⁴  Tea Majnarić⁵ 

[1] Clinical Hospital Center Osijek, Department of Radiotherapy and Oncology, 31000 Osijek, Croatia;Clinical Hospital Center Rijeka, Department of Radiotherapy and Oncology, 51000 Rijeka, Croatia;Department of Basic Medical Sciences, Faculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia;Family Medicine Practice, Community Health Center of Primorsko-Goranska County, 51000 Rijeka, Croatia;Institute of Emergency Medicine of Primorsko-Goranska County, 51000 Rijeka, Croatia;

关键词: breast cancer;    cancer;    public health;    smoking;    smoking cessation;   

DOI  :  10.3390/clinpract11030067

来源: DOAJ

【 摘 要 】

Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation vary dramatically between different populations, we aimed to analyze smoking prevalence in cancer patients, smoking cessation after cancer diagnosis, and the factors associated with smoking cessation in the setting of a developing country. We performed a cross-sectional survey on 695 patients in two clinical hospital centers. After cancer diagnosis, 15.6% of cancer patients stopped smoking. Male gender, younger age, and smoking-related cancer were the main factors associated with greater smoking cessation (p < 0.05). A total of 96% of breast cancer patients continued to smoke after cancer diagnosis and, compared to lung and colorectal cancer patients, exhibited a lower reduction in the number of cigarettes smoked (p = 0.023). An alarming rate of smoking prevalence was recorded in younger patients (45.6% at the time of cancer diagnosis) suggesting a future rise in smoking-related cancers and complications. These results should guide anti-smoking public health campaigns in transitional countries with a critical focus on younger and breast cancer patients.

【 授权许可】

Unknown